Eris Lifesciences Ltd. Conference Calls and Earnings Call Transcripts

Eris Lifesciences Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
1618.00
-0.61%
1618.00
-0.61%
1618.00
-0.61%
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2023, held on February 13, 2024, is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/financials/ (File name: Q3 FY24-Earnings Call Recording)
1618.00
-0.61%
1618.00
-0.61%
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended September 30, 2023, held on 08 November, 2023, is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/financials/
1618.00
-0.61%
1618.00
-0.61%
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended 30th June 2023, held on Monday, 07 August 2023, is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/financials/ (File name: Q1 FY24-Earnings Call Recording)
1618.00
-0.61%
Conference Call with Eris Lifesciences Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.
1618.00
-0.61%
1618.00
-0.61%
Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Dear Sir/Madam, In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we wish to inform you that the Audio Recording of the Earnings Conference Call in connection with the Consolidated and Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023, held on May 17, 2023, is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/financials/ (File name: Q4 FY23 Earnings Call Recording)

Earnings Calls Podcast on